Value-Based Care

A new initiative promises to help rural clinics access federal funds for telehealth, but it’s also a savvy growth play for the tech company behind it.

A small Colorado firm's award-winning floor, made from waste shells and backed by the military, signals a major shift in our reliance on fossil fuels.

CME Outfitters' award-winning IBD tool wasn't just built for patients; it was built with them. A deep dive into the new frontier of patient-led innovation.

A new study of 100M insurance claims reveals a shocking failure: nearly 9 in 10 women in some states get no osteoporosis care after a fracture. Why?

A silent health crisis affecting a billion women is becoming a major economic focus. One firm's move to train a new workforce signals a paradigm shift.

A new drug from Cambrian Bio shows promise in activating a key metabolic switch. This could lead to treatments that burn fat while preserving muscle mass.

A health AI company is adding top cardiologists to its board, signaling a strategic shift to prove that algorithms can solve real-world health crises.

Beyond the ribbon-cutting, Healthconnect Texas's new hub is the physical anchor for an ambitious plan to merge clinical and social data, reshaping care for 27M.

Dr. Glenn Parker's recent award is more than a trophy. It's a signal of a quiet revolution in healthcare—one that uses fintech to build national resilience.

A new spray-dried plasma could end reliance on freezers, transforming trauma care from the battlefield to rural ERs. But can Velico navigate the path to market?

Iceland's Alvotech secured a crucial capital infusion. It's a high-stakes play to survive financial pressures and compete in the next wave of affordable medicine.

A landmark partnership aims to bring data-driven transparency to senior care, combining industry ratings with a national PR campaign to redefine quality.

An Arkansas lab's $30 million settlement with the DOJ offers a rare look into 'lean lab' models and the fine line between business and patient care.

Central Garden & Pet's latest launch isn't just a cat treat; it's a calculated move into the underserved, high-growth feline calming market. Here's the strategy.

The hiring of Mark Whalen isn't just a personnel move; it's Banner Health's play to scale its nonprofit, value-based care network across the American West.

A Florida hospital just rebuilt a baby's heart in stages. It's not just a medical first; it's a new blueprint for innovation where execution trumps hype.

Model N's acquisition of Kalderos targets the chaotic 340B drug discount program, a system where 99% of pharma leaders lack real-time data visibility.

Phoenix Pathways isn't just a building; it's a new model for tackling chronic homelessness by integrating housing, healthcare, and human support under one roof.

A new partnership brings clinical AI to thousands of independent practices, promising to slash administrative costs and give doctors back their most valuable asset: time.

With 180-day exclusivity, Lupin's generic hypertension drug launch is set to disrupt a $53M market, highlighting a masterclass in pharmaceutical strategy.